Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 219

The DOI matches its Crossref record.

Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivo

Towatari, Takae, Nikawa, Takeshi, Murata, Mitsuo, Yokoo, Chihiro, Tamai, Masaharu, Hanada, Kazunori, Katunuma, Nobuhiko·1991·FEBS Letters

Abstract

New derivatives of E‐64 (compound CA‐030 and CA‐074) were tested in vitro and in vivo for selective inhibition of cathepsin B. They exhibited 10000–30000 times greater inhibitory effects on purified rat cathepsin B than on cathepsin H and L; their initial K 1 values for cathepsin B were about 2–5 nM, like that of E‐64‐c, whereas their initial K 1 values for cathepsins H and L were about 40–200 μM. In in vivo conditions, such us intraperitoneal injection of compound CA‐030 or CA‐074 into rats, compound CA‐074 is an especially potent selective inhibitor of cathepsin B, whereas compound CA‐030 does not show selectivity for cathepsin B, although both compounds CA‐030 and CA‐074 show complete selectivity for cathepsin B in vitro.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/0014-5793(91)80319-x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 219

Metadata

Authors
Towatari, T., Nikawa, T., Murata, M., Yokoo, C., Tamai, M., Hanada, K., & Katunuma, N.
Venue
FEBS Letters
Publisher
Wiley
Published
1991-03-25
Volume
280
Issue
2
Pages
311-315
ISSN
  • 0014-5793 (ISSN-L)
  • 1873-3468
OpenAlex
W2019091848
Cited by
219
References
0
FWCI
3.36
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivo. https://app.cochat.ai/papers/10.1016/0014-5793(91)80319-x
The paper
Towatari, T., Nikawa, T., Murata, M., Yokoo, C., Tamai, M., Hanada, K., & Katunuma, N. (1991). Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivo. FEBS Letters. https://doi.org/10.1016/0014-5793(91)80319-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.